{
    "clinical_study": {
        "@rank": "105795", 
        "arm_group": [
            {
                "arm_group_label": "Drug", 
                "arm_group_type": "Experimental", 
                "description": "V0498, Ibuprofen 25 mg"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and safety of repeated doses of a low\n      dosage of oromucosal Ibuprofen form (lozenge) versus placebo in patients suffering from\n      acute sore throat pain."
        }, 
        "brief_title": "Ibuprofen Lozenge in Acute Sore Throat Pain", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acute Sore Throat Pain", 
        "condition_browse": {
            "mesh_term": "Pharyngitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  male or female aged at least 18 years old\n\n          -  patient with an acute sore throat\n\n        Exclusion Criteria:\n\n          -  Severe respiratory tract infection (pneumonia, bronchitis or laryngitis)\n\n          -  Oro-pharyngeal paresthesia or mycosis\n\n          -  Severely traumatised and/or very severe oromucosal inflammation\n\n          -  Tonsillopharyngectomy\n\n          -  Peritonsillar abscess\n\n          -  Hypersensitivity to ibuprofen or other NonSteroidal Anti-Inflammatory Drugs (NSAIDs)\n             (including bronchospasm) or to excipients\n\n          -  Long term use (\u2265 3 times per week within the last month or regular intake within the\n             last 3 months before randomisation) of antiinflammatory drugs- Any long-acting or\n             slow release analgesic intake including NonSteroidal Anti-Inflammatory Drugs\n             (NSAIDs)within 24 hours before randomisation (e.g. piroxicam or naproxen)\n\n          -  Any anti-inflammatory drugs intake by systemic route within 12 hours before\n             randomisation\n\n          -  Any paracetamol intake within 6 hours before randomisation\n\n          -  Any cold medication (decongestant, antihistamine, expectorant, antitussive) within 6\n             hours before randomisation\n\n          -  Any topical throat medication intake containing or not a local oral anaesthetic such\n             as lozenge, spray, mouth rinse within 4 hours before randomisation\n\n          -  Heavy smokers (>20 cigarettes/day)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "427", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01785862", 
            "org_study_id": "V00498 TA 3 01", 
            "secondary_id": "2012-004423-20"
        }, 
        "intervention": [
            {
                "arm_group_label": "Drug", 
                "description": "Lozenge, Oromucosal administration", 
                "intervention_name": "Ibuprofen 25 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Lozenge matching V0498 lozenge, Oromucosal administration", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ibuprofen"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sore throat pain", 
            "tonsillopharyngitis", 
            "upper respiratory tract infection"
        ], 
        "lastchanged_date": "June 26, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Gi\u00e8res", 
                        "country": "France"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Erfurt", 
                        "country": "Germany"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Balvi", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daugavpils", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jekabpils", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jelgava", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kuldiga", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liepaja", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ogre", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ogres Municipality", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Riga", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saldus", 
                        "country": "Latvia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cardiff", 
                        "country": "United Kingdom"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Latvia", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of Efficacy and Safety of V0498 Versus Placebo in Acute Sore Throat Pain.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Germany: Ethics Commission", 
                "Latvia: State Agency of Medicines", 
                "Latvia: Institutional Review Board", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "United Kingdom: Research Ethics Committee"
            ]
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Total Pain Relief (TOTPAR) assessed on a 7-point rating scale called the Sore Throat Relief Scale (STRS) over 120min after the start of sucking of 1st study drug administered", 
            "measure": "Total Pain relief over 2 hours", 
            "safety_issue": "No", 
            "time_frame": "0-2 hours post-dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01785862"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pierre Fabre Medicament", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pierre Fabre Medicament", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}